Trump threatens 100% tariffs on generic drugs unless production moves to U.S.

President Donald Trump has threatened a 100% tariff on generic drugs from August 2028, rising to 200% in 2029, unless manufacturers move production to the U.S. The move, announced on social media, aims to "reshoring" pharmaceutical production and lower American drug prices, the world's highest. This policy expands on previous threats against branded medicines but may threaten the supply of low-cost drugs.

100% tariff threat

• ▪President Trump announced the tariff threat in a social media post
• ▪The tariff on generic drugs produced outside the U.S. would increase to 200% in August 2029
• ▪President Donald Trump threatened a 100% tariff on generic medicines, which would take effect in August 2028 for manufacturers who do not move production to the U.S.

Generic drug production reshoring

• ▪The proposed tariffs threaten the supply of low-cost medicines that millions of Americans rely on
• ▪The tariff threat is aimed at "reshoring" generic pharmaceutical production as part of President Trump's push to revive domestic manufacturing in the U.S.

Drug pricing policy tensions

• ▪The policy combines the goals of reviving domestic manufacturing and lowering drug prices, which may be difficult to reconcile
• ▪The tariff threat is an expansion of a strategy President Trump has used against the pharmaceutical industry since his second term began
• ▪A stated goal of President Trump's policy is to lower American drug prices, which have long been the world's highest
• ▪President Trump has previously threatened levies against makers of expensive branded medicines